Cargando…
Pharmacological ascorbate inhibits pancreatic cancer metastases via a peroxide-mediated mechanism
Pharmacological ascorbate (P-AscH(−), high-dose, intravenous vitamin C) is cytotoxic to tumor cells in doses achievable in humans. Phase I studies in pancreatic cancer (PDAC) utilizing P-AscH(−) have demonstrated increases in progression free survival, suggesting a reduction in metastatic disease bu...
Autores principales: | O’Leary, Brianne R., Alexander, Matthew S., Du, Juan, Moose, Devon L., Henry, Michael D., Cullen, Joseph J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572461/ https://www.ncbi.nlm.nih.gov/pubmed/33077776 http://dx.doi.org/10.1038/s41598-020-74806-2 |
Ejemplares similares
-
Pharmacologic Ascorbate and DNMT Inhibitors Increase DUOX Expression and Peroxide-Mediated Toxicity in Pancreatic Cancer
por: Steers, Garett J., et al.
Publicado: (2023) -
Auranofin and Pharmacologic Ascorbate as Radiomodulators in the Treatment of Pancreatic Cancer
por: Steers, Garett J., et al.
Publicado: (2022) -
A model for the detection of pancreatic ductal adenocarcinoma circulating tumor cells
por: Alexander, Matthew S., et al.
Publicado: (2018) -
Epigenetic effects of pharmacologic ascorbate
por: Steers, Garett J., et al.
Publicado: (2021) -
Catalase Modulates the Radio-Sensitization of Pancreatic Cancer Cells by Pharmacological Ascorbate
por: Du, Juan, et al.
Publicado: (2021)